Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray Stock Is Heading Higher Today

By George Budwell - Updated Jun 3, 2021 at 10:39AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An analyst upgrade is boosting the pot titan's shares.

What happened

Shares of the cannabis titan Tilray (TLRY 8.03%) jumped by as much as 15% in pre-market trading Thursday morning. The stock is responding positively to an upgrade from the financial services firm Cantor Fitzgerald that came out after the closing bell yesterday.

Specifically, Cantor Fitzgerald upgraded Tilray's stock to overweight from neutral. In an odd twist, however, the firm also lowered its 12-month price target from $30.25 to $22 in the same note to investors. 

A marijuana leaf and dried flower on a table containing stacks of U.S. currency.

Image source: Getty Images.

Despite this lower price target, though, the firm is still calling for Tilray's stock to rise by a healthy 15.7% over the next 12 months relative to Wednesday's closing price of $19. As of 9:40 a.m. EDT today, Tilray's stock was up by 12.26% in the wake of this analyst upgrade.  

So what

Cantor Fitzgerald analyst Pablo Zuanic cited Tilray's newfound strength -- both in its domestic market of Canada and internationally -- following its merger with Aphria as the reason for the upgrade. That's definitely a solid rationale for the firm's bullish outlook.    

Now what

Is Tilray stock worth owning at this point? With a market cap of roughly $9 billion, this mid-cap pot stock may not have much more room to run in the near term. The shares, after all, are now trading at close to 10 times 2022 projected revenue. That's not an outlandish valuation, but this top pot stock certainly isn't in bargain territory right now.

In short, investors might want to hang tight and wait for a more-compelling entry point. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
$3.50 (8.03%) $0.26
Canopy Growth Stock Quote
Canopy Growth
$2.65 (-2.21%) $0.06
Cronos Group Stock Quote
Cronos Group
$3.01 (1.35%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.